Immunic
IMUX
IMUX
62 hedge funds and large institutions have $36.9M invested in Immunic in 2023 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 16 increasing their positions, 14 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 13
90% less call options, than puts
Call options by funds: $55K | Put options by funds: $545K
Holders
62
Holding in Top 10
–
Calls
$55K
Puts
$545K
Top Buyers
| 1 | +$3.76M | |
| 2 | +$1.02M | |
| 3 | +$794K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$647K |
| 5 |
RI
RTW Investments
New York
|
+$645K |
Top Sellers
| 1 | -$2.52M | |
| 2 | -$931K | |
| 3 | -$885K | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$885K |
| 5 |
CAC
Cowen and Company
New York
|
-$645K |